These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 23453477)
21. Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: results of a phase II, randomized, placebo-controlled, dose-finding trial. Genovese MC; Kinnman N; de La Bourdonnaye G; Pena Rossi C; Tak PP Arthritis Rheum; 2011 Jul; 63(7):1793-803. PubMed ID: 21452293 [TBL] [Abstract][Full Text] [Related]
22. Predictors of response to rituximab in patients with active rheumatoid arthritis and inadequate response to anti-TNF agents or traditional DMARDs. Narvaez J; Díaz-Torné C; Ruiz JM; Hernandez MV; Torrente-Segarra V; Ros S; Rodriguez de la Serna A; Díaz-López C; Sanmartí R; Nolla JM Clin Exp Rheumatol; 2011; 29(6):991-7. PubMed ID: 22133052 [TBL] [Abstract][Full Text] [Related]
23. Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients. Ciechomska M; Bonek K; Merdas M; Zarecki P; Swierkot J; Gluszko P; Bogunia-Kubik K; Maslinski W Arch Immunol Ther Exp (Warsz); 2018 Oct; 66(5):389-397. PubMed ID: 29744553 [TBL] [Abstract][Full Text] [Related]
24. Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis. Bos WH; Bartelds GM; Wolbink GJ; de Koning MH; van de Stadt RJ; van Schaardenburg D; Dijkmans BA; Nurmohamed MT J Rheumatol; 2008 Oct; 35(10):1972-7. PubMed ID: 18785316 [TBL] [Abstract][Full Text] [Related]
25. [Effectiveness and safety of the treatment with tumour necrosis factor alpha antagonists in rheumatoid arthritis patients]. Arenere Mendoza M; Navarro Aznárez H; Rabanaque Hernández MJ; Manero Ruiz FJ Med Clin (Barc); 2005 Jun; 125(1):35-6. PubMed ID: 15960943 [No Abstract] [Full Text] [Related]
30. The effects of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis. Payet S; Pereira B; Soubrier M; Mathieu S Semin Arthritis Rheum; 2012 Feb; 41(4):e4-5; author reply e6. PubMed ID: 22154222 [No Abstract] [Full Text] [Related]
31. Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab. Lequerré T; Jouen F; Brazier M; Clayssens S; Klemmer N; Ménard JF; Mejjad O; Daragon A; Tron F; Le Loët X; Vittecoq O Rheumatology (Oxford); 2007 Mar; 46(3):446-53. PubMed ID: 16899502 [TBL] [Abstract][Full Text] [Related]
32. [TNF-alpha antagonists in therapy of rheumatoid arthritis]. Gross WL; Gause A Z Rheumatol; 2003 Jun; 62(3):217. PubMed ID: 12931691 [No Abstract] [Full Text] [Related]
33. Predictors of response to TNF inhibitors in rheumatoid arthritis - do we have new tools for personalized medicine? Simsek I Bull NYU Hosp Jt Dis; 2012; 70(3):187-90. PubMed ID: 23259626 [TBL] [Abstract][Full Text] [Related]
36. Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors. Kita J; Tamai M; Arima K; Nakashima Y; Suzuki T; Kawashiri SY; Okada A; Koga T; Yamasaki S; Nakamura H; Origuchi T; Aramaki T; Nakashima M; Fujikawa K; Tsukada T; Ida H; Aoyagi K; Uetani M; Eguchi K; Kawakami A Mod Rheumatol; 2012 Apr; 22(2):195-201. PubMed ID: 21898075 [TBL] [Abstract][Full Text] [Related]
37. Can baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis? Cuppen BV; Rossato M; Fritsch-Stork RD; Concepcion AN; Schenk Y; Bijlsma JW; Radstake TR; Lafeber FP; Arthritis Res Ther; 2016 Aug; 18(1):189. PubMed ID: 27558398 [TBL] [Abstract][Full Text] [Related]
38. Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study. Han BK; Kuzin I; Gaughan JP; Olsen NJ; Bottaro A Arthritis Res Ther; 2016 Apr; 18():93. PubMed ID: 27102921 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry). Glace B; Gottenberg JE; Mariette X; Philippe R; Pereira B; Lequerré T; Berthelot JM; Dougados M; Toussirot E; Pham T; Allanore Y; Loeuille D; Euller-Ziegler L; Soubrier M Ann Rheum Dis; 2012 Aug; 71(8):1429-31. PubMed ID: 22504557 [No Abstract] [Full Text] [Related]
40. [Is the response to anti-TNFalpha treatment influenced by the presence of IgM rheumatoid factor, in Rheumatoid Arthritis patients?]. Mourão AF; Santos FP; Falcão S; Barros R; Pinto TL; Mendes A; Castelão W; Nero P; Fonseca JE; Matos AA; Branco JC Acta Reumatol Port; 2008; 33(4):430-4. PubMed ID: 19078861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]